Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for Postoperative Delirium in Robotic Pancreaticoduodenectomy
NCT05274789Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Incidence of postoperative delirium. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)
Beyond the preview
Go deeper on NCT05274789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05274789.